Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Virology
|
November 8, 2019
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines
Gayathri Vijayakumar, Stephen McCroskery, Peter Palese
Journal of Hospital Medicine
|
November 16, 2022
Things We Do for No Reason™: Routine preoperative hemostatic testing for neurosurgical procedures
Helen Liu, Brandon Yeshoua, Stephen McCroskery, et al.
Journal of Intensive Care Medicine
|
February 6, 2023
Racial Disparities in Documented Chief Complaints and Diagnoses in Sepsis Patients
Helen Liu, Stephen McCroskery, Vignesh Rajasekaran, et al.
American Journal of Clinical Oncology
|
August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy
George Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology
|
February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy
Zakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer
|
October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)
Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Ebiomedicine
|
November 24, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
Weina Sun, Sarah R Leist, Stephen McCroskery, et al.
Biorxiv : the Preprint Server for Biology
|
August 4, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate
Weina Sun, Sarah R Leist, Stephen McCroskery, et al.
Microbiology Spectrum
|
June 6, 2022
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
Irene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
Vaccines
|
December 22, 2020
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Virology
|
November 8, 2019
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines
Gayathri Vijayakumar, Stephen McCroskery, Peter Palese
Journal of Hospital Medicine
|
November 16, 2022
Things We Do for No Reason™: Routine preoperative hemostatic testing for neurosurgical procedures
Helen Liu, Brandon Yeshoua, Stephen McCroskery, et al.
Journal of Intensive Care Medicine
|
February 6, 2023
Racial Disparities in Documented Chief Complaints and Diagnoses in Sepsis Patients
Helen Liu, Stephen McCroskery, Vignesh Rajasekaran, et al.
American Journal of Clinical Oncology
|
August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy
George Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology
|
February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy
Zakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer
|
October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)
Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Ebiomedicine
|
November 24, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
Weina Sun, Sarah R Leist, Stephen McCroskery, et al.
Biorxiv : the Preprint Server for Biology
|
August 4, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate
Weina Sun, Sarah R Leist, Stephen McCroskery, et al.
Microbiology Spectrum
|
June 6, 2022
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
Irene González-Domínguez, Jose Luis Martínez, Stefan Slamanig, et al.
Vaccines
|
December 22, 2020
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Weina Sun, Stephen McCroskery, Wen-Chun Liu, et al.
Page
of 2